Results 231 to 237 of about 45,216 (237)

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Lancet, The, 2011
Brian I Rini, Andrey Kaprin, C?zary A Szczylik   +2 more
exaly  

Sorafenib in Advanced Hepatocellular Carcinoma

New England Journal of Medicine, 2008
, Vincenzo Mazzaferro, Jean-Frédéric Blanc   +2 more
exaly  

Advances in targeted therapies for hepatocellular carcinoma in the genomic era

Nature Reviews Clinical Oncology, 2015
Josep M Llovet, Augusto Villanueva, Anja Lachenmayer   +2 more
exaly  

Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Journal of Clinical Oncology, 2006
Ghassan K Abou-Alfa, Armando Santoro, Jacques De Greve   +2 more
exaly  

New knowledge of the mechanisms of sorafenib resistance in liver cancer

Acta Pharmacologica Sinica, 2017
Hong-Yang Wang
exaly  

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

Nature Communications, 2019
Irene Oi-lin Ng, Chun-Ming Wong
exaly  

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

Nature Reviews Drug Discovery, 2006
Brian Schwartz
exaly